Physician profile
Kurt B Repke
NPI 1275532772
$3,652.43
in general payments reported to CMS, 2019-2025
19 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,260 · 2020: $168 · 2021: $370 · 2022: $374 · 2023: $729 · 2024: $244 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $750.17 | 2019-2020 | |
| Alcon Vision LLC | $513.78 | 2021-2024 | Argos, Clareon |
| Johnson & Johnson Surgical Vision, INC. | $376.07 | 2025 | Tecnis Iol |
| Bausch & Lomb Americas INC. | $330.58 | 2022-2025 | Miebo, Vyzulta |
| Ivantis, INC | $261.81 | 2019-2020 | |
| Glaukos Corporation | $226.42 | 2019-2022 | |
| Genentech USA, INC. | $217.80 | 2023 | |
| Sight Sciences, INC. | $163.79 | 2020-2022 | |
| Ocular Therapeutix, INC. | $161.32 | 2022-2024 | Dextenza |
| Sun Pharmaceutical Industries INC. | $145.87 | 2019 | |
| Rxsight INC | $134.71 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Aerie Pharmaceuticals, INC. | $120.48 | 2019 | |
| Horizon Therapeutics Plc | $107.39 | 2023 | Tepezza |
| New World Medical,INC. | $34.28 | 2023 | |
| Dompe US, INC. | $29.06 | 2025 | Oxervate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.38 | 2022 | |
| Biotissue Holdings INC. | $20.97 | 2025 | |
| Oyster Point Pharma, INC. | $18.97 | 2022 | |
| Allergan, INC. | $15.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Repke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.